Patents by Inventor Michael John Kleinig

Michael John Kleinig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of inducing melanogenesis in a subject
    Patent number: 10857208
    Abstract: Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: December 8, 2020
    Assignee: CLINUVEL PHARMACEUTICALS LIMITED
    Inventors: Michael John Kleinig, Thomas R. Tice, Jay K. Staas
  • METHODS OF INDUCING MELANOGENESIS IN A SUBJECT
    Publication number: 20180360919
    Abstract: Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.
    Type: Application
    Filed: August 27, 2018
    Publication date: December 20, 2018
    Applicant: Clinuvel Pharmaceuticals Limited
    Inventors: Michael John KLEINIG, Thomas R. TICE, Jay K. STAAS
  • Methods of inducing melanogenesis in a subject
    Patent number: 10076555
    Abstract: Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: September 18, 2018
    Assignee: Clinuvel Pharmaceuticals Limited
    Inventors: Michael John Kleinig, Thomas R. Tice, Jay K. Staas
  • METHODS OF INDUCING MELANOGENESIS IN A SUBJECT
    Publication number: 20160235819
    Abstract: Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.
    Type: Application
    Filed: April 21, 2016
    Publication date: August 18, 2016
    Applicant: Clinuvel Pharmaceuticals Limited
    Inventors: Michael John KLEINIG, Thomas R. TICE, Jay K. STAAS
  • Methods of inducing melanogenesis in a subject
    Patent number: 9345911
    Abstract: Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: May 24, 2016
    Assignee: Clinuvel Pharmaceuticals Limited
    Inventors: Michael John Kleinig, Thomas R. Tice, Jay K. Staas
  • Compositions and methods for including melanogenesis in a subject
    Patent number: 8569234
    Abstract: Described herein are compositions comprising an alpha-MSH analogue and a transdermal delivery system and methods for inducing melanogenesis and/or preventing UV radiation-induced skin damage in a subject by topical administration of these compositions.
    Type: Grant
    Filed: October 7, 2005
    Date of Patent: October 29, 2013
    Assignee: Clinuvel Pharmaceuticals Limited
    Inventors: Michael John Kleinig, Kenneth B. Kirby, Berno I. Pettersson, Jr.
  • Compositions and methods for including melanogenesis in a subject
    Publication number: 20110263508
    Abstract: Described herein are compositions comprising an alpha-MSH analogue and a transdermal delivery system and methods for inducing melanogenesis and/or preventing UV radiation-induced skin damage in a subject by topical administration of these compositions.
    Type: Application
    Filed: October 7, 2005
    Publication date: October 27, 2011
    Applicant: Clinuvel Pharmaceuticals Limited
    Inventors: Michael John Kleinig, Kenneth B. Kirby, Berno I. Pettersson, JR.
  • Methods of Inducing Melanogenesis in a Subject
    Publication number: 20080305152
    Abstract: Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.
    Type: Application
    Filed: February 11, 2005
    Publication date: December 11, 2008
    Applicant: CLINUVEL PHARMACEUTICALS LIMITED
    Inventors: Michael John Kleinig, Thomas R. Tice, Jay K. Staas
  • Antigenic preparation for treatment or prevention of helicobacter infection
    Patent number: 6663873
    Abstract: An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the lipopolysaccharide (LPS) of Helicobacter bacteria, particularly the LPS of H. pylori or H. felis, or an immunogenic fragment thereof.
    Type: Grant
    Filed: August 9, 1996
    Date of Patent: December 16, 2003
    Assignee: CSL
    Inventors: Christopher Vincent Doidge, Adrian Lee, Fiona Jane Buck, Elizabeth Pietrzykowski, Charles Alexander Quinn, Ian George Barr, Michael John Kleinig